ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

Questions Still Surround 88 BCDDP Patients Found With Minimal Cancer; DCCR Asks for Another Review

October 28, 1977

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Schmidt Says He Erred In Remarks About Pauling’s Grant Applications

March 23, 1979

B.J. Kennedy Receives ACCC Award, Says More Medical Oncologists Are Still Needed

April 5, 1985

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009